BridgeMD
Compares treatment options for Pudendal Neuralgia
Official title Conventional Versus High-Voltage Long-Duration Pulsed Radiofrequency of the Pudendal Nerve
ClinicalTrials.gov ID: NCT07356102
What this study is testing
- What it's testing
- This study is a single-center, prospective, randomized controlled trial evaluating two types of pulsed radiofrequency (PRF) treatment for patients with pudendal neuralgia. Pudendal neuralgia is a chronic neuropathic pain affecting the perineum and pelvic area, often causing significant discomfort and reduced quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older
- Diagnosis of pudendal neuralgia according to the Nantes diagnostic criteria
- Followed at the Algology (Pain Medicine) outpatient clinic
- Chronic pudendal neuralgia refractory to conservative treatment or intolerance to conservative therapies
- Not using neuropathic pain medications, or on a stable dose for at least 3 months prior to enrollment
You likely can't join if
- Presence of pelvic organic pathologies that may cause pudendal pain
- Pain limited only to the coccygeal, gluteal, or lower abdominal regions
- Patients with purely paroxysmal pain, isolated pruritus, or imaging findings that fully explain symptoms
- History of malignancy or autoimmune disease
- Previous surgery that may have altered the anatomy of the pudendal nerve region
- Pregnancy or suspected pregnancy
See the full eligibility criteria
- Adults aged 18 years or older
- Diagnosis of pudendal neuralgia according to the Nantes diagnostic criteria
- Followed at the Algology (Pain Medicine) outpatient clinic
- Chronic pudendal neuralgia refractory to conservative treatment or intolerance to conservative therapies
- Not using neuropathic pain medications, or on a stable dose for at least 3 months prior to enrollment
- Ability to comply with study procedures and follow-up visits
- Ability to understand the study information and provide written informed consent
- Presence of pelvic organic pathologies that may cause pudendal pain
- Pain limited only to the coccygeal, gluteal, or lower abdominal regions
- Patients with purely paroxysmal pain, isolated pruritus, or imaging findings that fully explain symptoms
- History of malignancy or autoimmune disease
- Previous surgery that may have altered the anatomy of the pudendal nerve region
- Pregnancy or suspected pregnancy
- Presence of a cardiac pacemaker or implanted electrical device
- Use of anticoagulant therapy or presence of uncorrectable coagulation disorders
- Active systemic infection or infection at the injection site
- Known hypersensitivity to metals
- Inability or unwillingness to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.